ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing
PRECISE-AD Phase 1b clinical trial in Alzheimer’s patients remains on track for unblinded 12-month t
PRECISE-AD Phase 1b clinical trial in Alzheimer’s patients remains on track for unblinded 12-month t